Evidence map›Paper›PMID 35903387›Full record

ArticleFrontiers in public health2022

Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.

Yufang Sun, Hang Dai, Ping Wang, Xiaodong Zhang, Dongliang Cui, Yongping Huang, Jimei Zhang, Tao Xiang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. A psychological insight of Moroccan adults' immunisation behaviour towards emergency vaccines.African journal of primary health care & family medicine · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yufang SunEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Hang DaiEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Ping WangEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Xiaodong ZhangEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Dongliang CuiEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Yongping HuangEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Jimei ZhangEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Tao XiangEmergency Department, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, The Second Affiliated Hospital Chengdu Clinical College of Chongqing Medical University, Chengdu, China.
Chongqing Medical University · CNChengdu Third People's Hospital · CNSouthwest Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The coronavirus disease 2019 (COVID-19) vaccines are considered to be an effective way to prevent the spread of the infection. Our previous study has shown that about 75% of healthcare workers (HCWs) in China were willing to receive the vaccine when it became available. Here, we examined the acceptance of a third booster dose among Chinese people and identified the influencing factors. Methods: A cross-sectional online survey was conducted and the snowball sampling method was utilized. An online questionnaire was provided to all the participants in the form of a quick response (QR) code. The questionnaire included general demographic information, views on vaccines, the General Health Questionnaire-12 (GHQ-12), and the Depression, Anxiety, and Stress Scale-21 (DASS-21). The univariate analysis was done between all the variables and our dependent variable. Then, we used the multivariate logistic regression model to examine the influencing factors of the third booster dose acceptance. Results: We collected 1,062 complete answers. Of these, 90.39% ( Conclusion: This study revealed that Chinese people were very receptive to the third booster dose, which is an inspiring result. More positive attitudes regarding COVID-19 vaccination were supported by its efficacy and few side effects.

Indexed as

COVID-19COVID-19 VaccinesChinaCross-Sectional StudiesHumansSARS-CoV-2COVID-19 VaccinesacceptanceChinese peopleCOVID-19third booster dosevaccine

Identifiers

PMID35903387
PMCPMC9315287
OpenAlexW4285040785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.